AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-714135_ITM" title="Facts and information about STREAMLINING DRUG APPROVAL.">STREAMLINING DRUG APPROVAL.</a>
Close
Set up an RSS feed that alerts you when new articles from OB GYN News are available.
Frequently asked questions about RSS feeds
STREAMLINING DRUG APPROVAL.
Promising drugs for cancer and other serious conditions must be made more readily available for compassionate use, the delegates ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Streamlining drug approval; More clinical trials won't improve safety.(OPED)
- Newspaper article from: The Washington Times June 22, 2006 700+ words
...essentially constant at about 2 or 3 percent, even as the number of required clinical studies a current average of 120 per drug approval has mushroomed. In fact, improper use of otherwise-safe medicines remains the problem. Common over-the-counter painkillers...
- Streamlining drug discovery.(Industrial: Emerging Technologies)(Commonwealth of...
- Magazine article from: R & D August 1, 2005 700+ words
Image analysis software from Australian-based CSIRO (Commonwealth of Scientific and Industrial Research Organisation) is being used to find new treatments for neurological disorders, such as Parkinson's, by measuring nerve cell changes. According to CSIRO. the software operates "faster and more
- Argonaut Introduces New Kit for Streamlining Drug Discovery.
- Press release article from: PR Newswire June 17, 2003 700+ words
Argonaut Technologies, Inc. today announced the Reductive Amination Toolkit to simplify the incorporation of this important reaction into chemical drug discovery and the development of novel drug candidates. Approximately 75% of all the chemical drugs currently in development could utilize this
- ON24 Video Investor Alert: Director: Proteomics Streamlining Drug Discovery...
- Press release article from: Business Wire June 21, 2001 700+ words
Business Editors & Analysts BUSINESS WIRE) Dr. Brad Guild of Millennium Pharmaceuticals discusses the areas MLNM is directing its proteomics research. For the complete streaming video story users should access httpwww.on24.com/index.html?id=60223&type=av&ref=bizwire Ticker:
- Pharsight Corporation Unveils Enhanced Web Site Dedicated to Streamlining Drug...
- Press release article from: Business Wire October 14, 1997 700+ words
PALO ALTO, CalifBW HealthWireOct. 14, 1997-- www.pharsight.com Provides Superior Online Information about Methods to Accelerate Clinical Trials Pharsight Corporation, a leading provider of clinical trial design software to accelerate the drug development process, today announced a comprehensive
- Crystallize Your Business Decisions With Drug Approval Trends At The FDA And...
- Press release article from: M2 Presswire May 13, 2008 700+ words
...Crystallize Your Business Decisions With Drug Approval Trends At The FDA And EMEA Report...c91637) has announced the addition of "Drug Approval Trends at the FDA and EMEA: Process...Industry Response" to their offering Drug Approval Trends at the FDA and EMEA - Process...
- Drug Approval Process in Europe - an Outlook.
- Newspaper article from: Biotech Week June 3, 2009 700+ words
...researchandmarkets.com/research/e59125/drug_approval_proc) has announced the addition of Frost & Sullivan's new report "Drug Approval Process in Europe - An Outlook" to...This research deals with the drug approval process in Europe by focussing on the...
- Drug Approval Process in Europe - An Outlook.
- Press release article from: M2 Presswire May 15, 2009 700+ words
...15 May 2009-Research and Markets: Drug Approval Process in Europe - An Outlook(C...researchandmarkets.com/research/e43eb1/drug_approval_proc) has announced the addition of Frost & Sullivan's new report "Drug Approval Process in Europe - An Outlook" to...
Source: HighBeam Research, STREAMLINING DRUG APPROVAL.